	Breast MRI With Abbreviated Reading Protocol as Additional Evaluation Tool for Suspicious Microcalcifications in a Screening Cohort: Diagnostic Performance and Interreader Agreement. Anticancer Res Pöschke P, Wenkel E, Schulmeyer C, Hack CC, Beckmann MW, Janka R, Brehm B, Peter SC, Ohlmeyer S. PMID: 42674718 [PubMed - indexed for MEDLINE]
	Predictors of Discontinuation of Eribulin Therapy for Metastatic Breast Cancer: A Retrospective Cohort Study. Anticancer Res Hata C, Hata T, Hosomi K, Kataoka N, Nishihara M, Kimura K, Iwamoto M, Ashida A. PMID: 42674716 [PubMed - indexed for MEDLINE]
	Advances in Gynecologic Tumor-associated Lymphatic Vessels. Anticancer Res Xu P, Xiang M, Liu F. PMID: 42674698 [PubMed - indexed for MEDLINE]
	A Case of Concurrent Liver Metastases from Colorectal and Breast Cancer Diagnosed Using Percutaneous Tumor Biopsy. Anticancer Res Yusa T, Masuda T, Tomiguchi M, Nagayama Y, Miyamoto H, Komohara Y, Takematsu T, Adachi Y, Oda E, Ishiko T, Beppu T. PMID: 42674684 [PubMed - indexed for MEDLINE]
	Is Tumor Bed Boost Necessary in Young Patients With Margin-negative Invasive Ductal Carcinoma in the Modern Radiotherapy Era? Anticancer Res Wang Y, Jingu K, Takahashi N, Yamamoto T, Umezawa R. PMID: 42674682 [PubMed - indexed for MEDLINE]
	De-escalation of Breast Cancer Screening Supported by Population Data and Tumor Biology. Ann Intern Med Welch HG, Jørgensen KJ, Dossett LA. PMID: 42673595 [PubMed - as supplied by publisher]
	Plant-Based Î±-Linolenic Acid as a Superior Nutraceutical to Modulates Apoptosis, Hypoxic Signaling, and Lipid Metabolic Pathway in Breast Cancer: A Comparative Preclinical Study. Mol Nutr Food Res Kumar A, Verma P, Rahul NS, Kaithwas G. PMID: 42671985 [PubMed - indexed for MEDLINE]
	Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study. Breast Cancer Res Treat Tian Z, Li H, Deng Y, Yao H, Wang Y, Jin L, Deng H, Chen N, Liu J. PMID: 42671642 [PubMed - indexed for MEDLINE]
	Feasibility of EHR-Based Prescreening for an Adjuvant Breast Cancer Trial in a Safety-Net Health System. Oncologist Alkhafaji H, Reynolds LCK, Howell M, Henderson JD, Preece D, Teigen KJ, Gerber DE, Narra K. PMID: 42671355 [PubMed - as supplied by publisher]
	A Habitat Imaging-Based Radiomics and Deep Learning Fusion for Preoperative Prediction of Lymphovascular Invasion in Invasive Breast Cancer: A Multicenter Study. Balkan Med J Zhong L, Wang K, Xie J, Shi L, Gu L, Zheng Y, Yi X. PMID: 42671326 [PubMed - as supplied by publisher]
	The performance and role of BI-RADS classification in predicting malignancy in non-palpable breast lesions. Malays J Pathol Abu N, Lai SK, Hussin H, Shamsudin NH. PMID: 42671236 [PubMed - indexed for MEDLINE]
	HER2 ultralow in metastatic breast cancer: Diagnostic boundaries in the era of antibody-drug conjugates. Malays J Pathol Ch'ng ES. PMID: 42671229 [PubMed - indexed for MEDLINE]
	The KPROCS Study: A Real-World and Research Resource to Investigate Multilevel Determinants of Ovarian Cancer Treatment and Survival. Cancer Epidemiol Biomarkers Prev Bandera EV, Doherty JA, Lee VS, Collin LJ, Kavecansky J, Khosrow-Khavar F, Li J, Moy LM, Chirikova E, Inamdar PP, Shariff-Marco S, Grieshober L, Köbel M, Gomez SL, Kushi LH. PMID: 42671158 [PubMed - as supplied by publisher]
	Outcome of an intervention based on adjusting the threshold for hyponatremia in patients undergoing myomectomy: A case control study. Afr J Reprod Health Yang Z, Wang L, Wang Y, Liu Z, Ai H, Pei W, Xu S, Lu L, Luo J. PMID: 42670791 [PubMed - indexed for MEDLINE]
	Developments in human papillomavirus vaccines, schedules, and implementation strategies. J Natl Cancer Inst Monogr Bruni L, Brotons M, Alvarez J, Roden RBS. PMID: 42670627 [PubMed - indexed for MEDLINE]
	Benefits, harms, and cervical cancer elimination timing of human papillomavirus screening approaches tailored to birth cohort as a proxy for vaccination status in the United States: a comparative modeling study. J Natl Cancer Inst Monogr Simms KT, de Bondt D, Killen J, Sy S, Naslazi E, Regan MC, Burger EA, Kim JJ, Smith MA, de Kok IMCM, Canfell K. PMID: 42670626 [PubMed - indexed for MEDLINE]
	From evidence to practice: leveraging implementation science for transitioning to risk-adapted cervical cancer screening. J Natl Cancer Inst Monogr Adsul P, Adcock R. PMID: 42670625 [PubMed - indexed for MEDLINE]
	Cervical cancer screening in vaccinated populations: challenges and implications for low- and middle-income countries. J Natl Cancer Inst Monogr Almonte M, Tejada RA, Calderón A, Baena A. PMID: 42670624 [PubMed - indexed for MEDLINE]
	Deintensification of cervical cancer screening in the era of high human papillomavirus-vaccination coverage. J Natl Cancer Inst Monogr Bonde J, Castle PE. PMID: 42670623 [PubMed - indexed for MEDLINE]
	How to evaluate and select cervical screening and triage tests in vaccinated populations. J Natl Cancer Inst Monogr Wentzensen N, Arbyn M, Poljak M. PMID: 42670622 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 334441

Page 1 of 16723



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy